Navigation Links
New fertility drug development techniques by Organon

In the 7th International Symposium on GnRH Analogs in Cancer and Human Reproduction, Organon presented new techniques of development of fertility drugs. Organon scientists have succeeded in customizing the follicle-stimulating hormone(FSH) molecule by adding a hybrid subunit, which extends FSH's active life. This was achieved through an international collaboration. This longer active life will mean fewer injections for the infertile patient, making the treatment less difficult// and more patient-friendly. The company indicated that a long-acting form of the genetically-produced fertility drug, Puregon(rFSH), has moved into the dose-finding phase of its development using the latest techniques of "knowledge driven drug development" (KD3). These new techniques model the drug's underlying mechanisms, and use that information to support decisions about doses, dose regimens and design of future trials.

Organon is also in the process of developing oral tablet formulation alternative to the injectable hormone hCG (human chorionic gonadotropin). hCG has been used, in the past 30 years, to make ovulation and final oocyte maturation take place with precise timing. However, it has only been available in the injectable form due to its high molecular weight. Now, scientists have identified through high-throughput screening, compounds similar to hCG, but with lower molecular weight. These compounds have been optimized with respect to potency, selectivity and safety. The new compound, an LH/hCG agonistic agent, interacts with the human LH receptor just like LH (and hCG). Scientists carried out pre-clinical tests of this LH agonist in rats and found that it induced ovulation after a single oral dose and that fertilization of the ovulated eggs resulted in the normal implantation of healthy embryos in these rats. The scientists at Organon who are also exploring the IVF cycle concluded that this oral compound could also play a role in other infertility indications or at othe r moments during and after an IVF cycle.


'"/>




Related medicine news :

1. Male infertility in relation to cancer
2. Male infertility in relation to pesticide
3. Infertility in relation with virus
4. Shapely sperm-a valuable indicator of fertility
5. Relief to pregnant women using fertility drugs
6. How to repeal male infertility?
7. Benefits in fertility procedures
8. Endometriosis connected to fertility
9. Mountain biking connected to infertility
10. Reduced fertility in men who mountain bike
11. Infertility may result from bone fragments
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... June 25, 2016 , ... Experts from ... at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center ... care topics including advance care planning, healthcare costs and patient and family engagement. ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
(Date:6/24/2016)... ... ... crisis. Her son James, eight, was out of control. Prone to extreme mood shifts and ... him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife on ... say he was going to kill them. If we were driving on the freeway, ...
(Date:6/24/2016)... ... 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited to ... Recovery® program to drive cancer patients to and from their cancer treatments. Comfort ... quality of life and ongoing independence. Getting to and from medical treatments is ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... 24, 2016 ... the addition of the " Global Markets for ... This report focuses on ... updated review, including its applications in various applications. The ... which includes three main industries: pharmaceutical and biotechnology, food ...
(Date:6/24/2016)... ALEXANDRIA, Va. , June 24, 2016 ... a set of recommendations that would allow ... information (HCEI) with entities that make formulary and coverage ... determine the "value" of new medicines. The ... that does not appear on the drug label, a ...
Breaking Medicine Technology: